Proteomic characterization of EVs mimicking “first contact” conditions of tumor-stromal interactions resulted in the identification of KIF5B and SFRP2 as promising early biomarkers that are expressed in progressive stages of pancreatic cancer. This evidence concerns the gene SFRP2 and pancreatic neoplasm.